Health Care Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization
Jan
8
2019
FDA 2018 Year in Review: Cannabis McDermott Will & Emery
Jan
8
2019
FDA 2018 Year in Review: Tobacco McDermott Will & Emery
Jan
8
2019
FDA 2018 Year in Review: Laboratory-Developed Tests and Precision Medicine McDermott Will & Emery
Jan
8
2019
FDA 2018 Year in Review: Medical Devices McDermott Will & Emery
Jan
8
2019
FDA 2018 Year in Review: Drug Supply Chain Security Act McDermott Will & Emery
Jan
8
2019
Connecticut Superior Court Ruling Addresses 2016 Physician Non-Compete Law Robinson & Cole LLP
Jan
8
2019
FDA 2018 Year in Review: Digital Health McDermott Will & Emery
Jan
8
2019
FDA 2018 Year in Review McDermott Will & Emery
Jan
8
2019
HHS Issues Cybersecurity Practices for Health Care Industry Robinson & Cole LLP
Jan
8
2019
FDA 2018 Year in Review: Advertising and Promotion McDermott Will & Emery
Jan
8
2019
Day 1 Notes on the 2019 JP Morgan Healthcare Conference Sheppard, Mullin, Richter & Hampton LLP
Jan
8
2019
New Jersey January 7, 2019 Health Care Regulatory Developments Giordano, Halleran & Ciesla, P.C.
Jan
8
2019
FDA 2018 Year in Review: Food McDermott Will & Emery
Jan
8
2019
Federal District Court Rules HHS Cuts to 340B Reimbursement 'Exceeded' Authority Dinsmore & Shohl LLP
Jan
8
2019
FDA 2018 Year in Review: Drug Quality Security Act Implementation McDermott Will & Emery
Jan
8
2019
FDA 2018 Year in Review: Drugs McDermott Will & Emery
Jan
8
2019
DC District Court Holds that Medicare Payment Cuts for 340B Drugs Exceeded Agency’s Authority Foley & Lardner LLP
Jan
7
2019
Health Care Fraud Leads $2.8 Billion Collected for False Claims Squire Patton Boggs (US) LLP
Jan
7
2019
DOJ Updates its Justice Manual to Include Section Limiting Use of Guidance Documents in Litigation Mintz
Jan
7
2019
“Pathways to Success” Update: CMS Issues Final Rule on Changes to the ACO Program Sheppard, Mullin, Richter & Hampton LLP
Jan
7
2019
New Ohio Standard Authorization Forms for Use and Disclosure of Protected Health Information Dinsmore & Shohl LLP
Jan
7
2019
Promising Results of Aurodox Study Suggest Potential Treatment for E. coli Infection Keller and Heckman LLP
Jan
7
2019
“Pathways to Success:” CMS Publishes Final Rule Modifying the Medicare Shared Savings Program
Jan
7
2019
Federal Court Denies Bifurcation of Contract Claims and Uberrimae Fidei and Late Notice Defenses in Reinsurance Dispute Carlton Fields
Jan
7
2019
FTA and USCG Raise Random Drug Testing Rates to 50% for 2019 Jackson Lewis P.C.
Jan
4
2019
Federal Court Held HHS Lacks the Authority to Impose Dramatic 340B Reimbursement Rate Reduction Squire Patton Boggs (US) LLP
Jan
4
2019
The Importance of Diligence in Orthopedic Recapitalization Transactions Foley & Lardner LLP
Jan
4
2019
EPA Denies Section 21 Petition Seeking Increased Asbestos Reporting Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins